METTL9 and hepatocellular carcinoma: Next, to investigate whether METTL9 induced HCC progression via mediating ferroptosis, we treated METTL9 knockdown cells with ferroptosis inhibitor ferrostatin-1 (Fer-1) and METTL9 overexpression cells with Erastin in vitro.